Meet the Evaluate Team: Magda Lis-Podjaska | Evaluate
Our Voice of the Customer lead, Magda Lis-Podjaska, shares her views on biopharma, CDMO and challenges for biotechs.| Evaluate
Our Voice of the Customer lead, Magda Lis-Podjaska, shares her views on biopharma, CDMO and challenges for biotechs.| Evaluate
Biopharma faces ongoing challenges in 2024, yet Q3 IPOs and venture funding show promise. M&A remains low. Dive into our latest analysis.| Evaluate
MASH UP? Are we witnessing the next multi-billion dollar breakthrough in liver health? Explore the possibilities in our latest eBook.| Evaluate
